Chimerix Stock Buy Hold or Sell Recommendation
| CMRX Stock | USD 0.91 0.03 3.41% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Chimerix is 'Strong Sell'. Macroaxis provides Chimerix buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Chimerix positions. The advice algorithm takes into account all of Chimerix's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Chimerix's buy or sell advice are summarized below:
Real Value 2.41 | Target Price 7 | Hype Value 0.91 | Market Value 0.91 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Chimerix given historical horizon and risk tolerance towards Chimerix. When Macroaxis issues a 'buy' or 'sell' recommendation for Chimerix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Chimerix |
Execute Chimerix Buy or Sell Advice
The Chimerix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Chimerix. Macroaxis does not own or have any residual interests in Chimerix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Chimerix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Chimerix Trading Alerts and Improvement Suggestions
| Chimerix has some characteristics of a very speculative penny stock | |
| Chimerix had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 324 K. Net Loss for the year was (82.09 M) with loss before overhead, payroll, taxes, and interest of (36.49 M). | |
| Chimerix currently holds about 42.79 M in cash with (69.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Chimerix has a poor financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
Chimerix Returns Distribution Density
The distribution of Chimerix's historical returns is an attempt to chart the uncertainty of Chimerix's future price movements. The chart of the probability distribution of Chimerix daily returns describes the distribution of returns around its average expected value. We use Chimerix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Chimerix returns is essential to provide solid investment advice for Chimerix.
| Mean Return | -0.03 | Value At Risk | -5.21 | Potential Upside | 4.95 | Standard Deviation | 3.64 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Chimerix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Chimerix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chimerix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chimerix backward and forwards among themselves. Chimerix's institutional investor refers to the entity that pools money to purchase Chimerix's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bridgeway Capital Management, Llc | 2023-12-31 | 1 M | Geode Capital Management, Llc | 2023-12-31 | 912.8 K | Barclays Plc | 2023-12-31 | 891.7 K | Northern Trust Corp | 2023-12-31 | 690.3 K | Tejara Capital Ltd | 2023-12-31 | 550.1 K | Yakira Capital Management, Inc. | 2023-12-31 | 508.4 K | Assenagon Asset Management Sa | 2023-12-31 | 499.4 K | Bank Of New York Mellon Corp | 2023-12-31 | 425.5 K | Adage Capital Partners Gp Llc | 2023-12-31 | 400 K | Ra Capital Management, Llc | 2023-12-31 | 8.8 M | Monaco Asset Management | 2023-12-31 | 4.4 M |
Chimerix Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (64.2M) | 30.1M | (31.6M) | 10.4M | 1.8M | 1.9M | |
| Free Cash Flow | (75.3M) | (36.1M) | (100.1M) | (46.9M) | (69.3M) | (72.8M) | |
| Depreciation | 564K | 402K | 167K | 98K | 1K | 950.0 | |
| Other Non Cash Items | 34.8M | (14K) | 57.7M | (231.0M) | (8.0M) | (8.5M) | |
| Capital Expenditures | 158K | 58K | 207K | 71K | 89K | 84.6K | |
| Net Income | (112.6M) | (43.5M) | (173.2M) | 172.2M | (82.1M) | (86.2M) | |
| End Period Cash Flow | 16.9M | 47.0M | 15.4M | 25.8M | 27.7M | 33.1M | |
| Change To Inventory | (5K) | 4.3M | 186K | (2.8M) | (2.5M) | 0.0 | |
| Investments | 10.8M | 64.8M | (43.9M) | (163.9M) | (185.9M) | (176.6M) | |
| Change Receivables | (903K) | 893K | 340K | (1.0M) | (936K) | (889.2K) | |
| Change To Netincome | 44.7M | 5.6M | 12.3M | (214.4M) | (192.9M) | (183.3M) |
Chimerix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chimerix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chimerix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chimerix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | 0.25 | |
σ | Overall volatility | 3.76 | |
Ir | Information ratio | -0.03 |
Chimerix Volatility Alert
Chimerix exhibits very low volatility with skewness of 0.3 and kurtosis of 4.14. Chimerix is a potential penny stock. Although Chimerix may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Chimerix. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Chimerix instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Chimerix Fundamentals Vs Peers
Comparing Chimerix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Chimerix's direct or indirect competition across all of the common fundamentals between Chimerix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Chimerix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Chimerix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Chimerix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Chimerix to competition |
| Fundamentals | Chimerix | Peer Average |
| Return On Equity | -0.36 | -0.31 |
| Return On Asset | -0.24 | -0.14 |
| Current Valuation | (102.12 M) | 16.62 B |
| Shares Outstanding | 89.21 M | 571.82 M |
| Shares Owned By Insiders | 1.34 % | 10.09 % |
| Shares Owned By Institutions | 50.01 % | 39.21 % |
| Number Of Shares Shorted | 1.24 M | 4.71 M |
| Price To Earning | (3.43) X | 28.72 X |
| Price To Book | 0.44 X | 9.51 X |
| Price To Sales | 264.52 X | 11.42 X |
| Revenue | 324 K | 9.43 B |
| Gross Profit | (36.49 M) | 27.38 B |
| EBITDA | (93.06 M) | 3.9 B |
| Net Income | (82.09 M) | 570.98 M |
| Cash And Equivalents | 42.79 M | 2.7 B |
| Cash Per Share | 0.49 X | 5.01 X |
| Total Debt | 2.14 M | 5.32 B |
| Debt To Equity | 0.1 % | 48.70 % |
| Current Ratio | 2.18 X | 2.16 X |
| Book Value Per Share | 2.17 X | 1.93 K |
| Cash Flow From Operations | (69.25 M) | 971.22 M |
| Short Ratio | 2.51 X | 4.00 X |
| Earnings Per Share | (0.93) X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 72 | 18.84 K |
| Beta | 1.1 | -0.15 |
| Market Capitalization | 78.9 M | 19.03 B |
| Total Asset | 212.77 M | 29.47 B |
| Retained Earnings | (795.52 M) | 9.33 B |
| Working Capital | 170.67 M | 1.48 B |
| Current Asset | 228.84 M | 9.34 B |
| Current Liabilities | 20.18 M | 7.9 B |
| Net Asset | 212.77 M |
Note: Acquisition by Melemed Allen S. of 25740 shares of Chimerix subject to Rule 16b-3 [view details]
Chimerix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Chimerix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 12550.54 | |||
| Daily Balance Of Power | 0.6 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.91 | |||
| Day Typical Price | 0.91 | |||
| Price Action Indicator | 0.02 | |||
| Period Momentum Indicator | 0.03 |
About Chimerix Buy or Sell Advice
When is the right time to buy or sell Chimerix? Buying financial instruments such as Chimerix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 16.4M | 2.1M | 2.1M | 3.7M | Total Assets | 100.5M | 279.3M | 212.8M | 197.0M |
Use Investing Ideas to Build Portfolios
In addition to having Chimerix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wholesale Thematic Idea Now
Wholesale
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Chimerix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Chimerix Stock analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Chimerix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chimerix. If investors know Chimerix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chimerix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.004 | Quarterly Revenue Growth (0.99) | Return On Assets (0.24) | Return On Equity (0.36) |
The market value of Chimerix is measured differently than its book value, which is the value of Chimerix that is recorded on the company's balance sheet. Investors also form their own opinion of Chimerix's value that differs from its market value or its book value, called intrinsic value, which is Chimerix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chimerix's market value can be influenced by many factors that don't directly affect Chimerix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chimerix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chimerix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chimerix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.